Insights
Harnessing Vecura’s AI Platform to Design FGFR4-Targeting Peptides for Hepatocellular Carcinoma Therapy
Hepatocellular carcinoma (HCC) is the predominant primary liver cancer and a major cause of cancer-related mortality worldwide. Despite advances in current therapies, advanced HCC remains difficult to treat, highlighting the need for new therapeutic targets.